GlowDx

GlowDx has developed the worlds first Artificially Intelligent Point-of-Care (POC) Diagnostics Platform, aimed at tackling Infectious Disease in Developing Countries. Our first Assay detects DENV, ZIKV & CHIKV (Arboviruses - TAM: >$4B), while our AI utilizes machine learning to model & predict future outbreaks.

REQUEST INTRODUCTION USING

LINKEDIN ANGELLIST